Terms: = Sarcomas AND TNFAIP3, TNFA1P2, 7128, ENSG00000118503, OTUD7C, MGC138687, MGC104522, A20, MGC138688, P21580
21 results:
1. Kaposiform hemangioendothelioma presented with raynaud phenomenon: a case report.
Liu L; Gu W; Teng L; Xu Y; Zheng F; Hu M; Lu M; Xu X
BMC Pediatr; 2023 Nov; 23(1):574. PubMed ID: 37978357
[TBL] [Abstract] [Full Text] [Related]
2. RNA-guided gene editing of the murine gammaherpesvirus 68 genome reduces infectious virus production.
Foreman HC; Kirillov V; Paniccia G; Catalano D; Andrunik T; Gupta S; Krug LT; Zhang Y
PLoS One; 2021; 16(6):e0252313. PubMed ID: 34086743
[TBL] [Abstract] [Full Text] [Related]
3. Fine needle aspiration of an intranodal follicular dendritic cell sarcoma: A case report with molecular analysis and review of the literature.
Andersen MJ; Kerr DA; Lisovsky M; Vaickus LJ; Linos K
Diagn Cytopathol; 2021 Feb; 49(2):E65-E70. PubMed ID: 32816379
[TBL] [Abstract] [Full Text] [Related]
4. Genetic heterogeneity of pediatric systemic lupus erythematosus with lymphoproliferation.
Li G; Li Y; Liu H; Shi Y; Guan W; Zhang T; Yao W; Wu B; Xu H; Sun L
Medicine (Baltimore); 2020 May; 99(20):e20232. PubMed ID: 32443356
[TBL] [Abstract] [Full Text] [Related]
5. Subsequent development of histiocytic sarcoma and follicular lymphoma: cytogenetics and next-generation sequencing analyses provide evidence for transdifferentiation of early common lymphoid precursor-a case report and review of literature.
Péricart S; Waysse C; Siegfried A; Struski S; Delabesse E; Laurent C; Evrard S
Virchows Arch; 2020 Apr; 476(4):609-614. PubMed ID: 31807922
[TBL] [Abstract] [Full Text] [Related]
6. Targetable Alterations in Adult Patients With Soft-Tissue sarcomas: Insights for Personalized Therapy.
Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
[TBL] [Abstract] [Full Text] [Related]
7. Effects of DLC1 Deficiency on Endothelial Cell Contact Growth Inhibition and Angiosarcoma Progression.
Sánchez-Martín D; Otsuka A; Kabashima K; Ha T; Wang D; Qian X; Lowy DR; Tosato G
J Natl Cancer Inst; 2018 Apr; 110(4):390-399. PubMed ID: 29202196
[TBL] [Abstract] [Full Text] [Related]
8. Establishment and analysis of osteosarcoma cell sublines with different metastatic characteristics.
Li Z; Li Y; Wang N; Yang L; Zhao W; Zeng X
Tumour Biol; 2014 Sep; 35(9):8591-6. PubMed ID: 24863941
[TBL] [Abstract] [Full Text] [Related]
9. miR-29 acts as a decoy in sarcomas to protect the tumor suppressor a20 mRNA from degradation by HuR.
Balkhi MY; Iwenofu OH; Bakkar N; Ladner KJ; Chandler DS; Houghton PJ; London CA; Kraybill W; Perrotti D; Croce CM; Keller C; Guttridge DC
Sci Signal; 2013 Jul; 6(286):ra63. PubMed ID: 23901138
[TBL] [Abstract] [Full Text] [Related]
10. The antibody-based targeted delivery of interleukin-4 and 12 to the tumor neovasculature eradicates tumors in three mouse models of cancer.
Hemmerle T; Neri D
Int J Cancer; 2014 Jan; 134(2):467-77. PubMed ID: 23818211
[TBL] [Abstract] [Full Text] [Related]
11. a20/tnfaip3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.
Sakakibara S; Espigol-Frigole G; Gasperini P; Uldrick TS; Yarchoan R; Tosato G
Oncogene; 2013 Mar; 32(10):1223-32. PubMed ID: 22525270
[TBL] [Abstract] [Full Text] [Related]
12. a20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner.
Matta H; Gopalakrishnan R; Punj V; Yi H; Suo Y; Chaudhary PM
J Biol Chem; 2011 Jun; 286(24):21555-64. PubMed ID: 21531730
[TBL] [Abstract] [Full Text] [Related]
13. Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma.
Daigeler A; Chromik AM; Haendschke K; Emmelmann S; Siepmann M; Hensel K; Schmitz G; Klein-Hitpass L; Steinau HU; Lehnhardt M; Hauser J
Ultrasound Med Biol; 2010 Nov; 36(11):1893-906. PubMed ID: 20870344
[TBL] [Abstract] [Full Text] [Related]
14. The ruthenium complex cis-(dichloro)tetraammineruthenium(III) chloride presents selective cytotoxicity against murine B cell lymphoma (A-20), murine ascitic sarcoma 180 (S-180), human breast adenocarcinoma (SK-BR-3), and human T cell leukemia (Jurkat) tumor cell lines.
Silveira-Lacerda Ede P; Vilanova-Costa CA; Hamaguchi A; Pavanin LA; Goulart LR; Homsi-Brandenburgo MI; Dos Santos WB; Soares AM; Nomizo A
Biol Trace Elem Res; 2010 Jun; 135(1-3):98-111. PubMed ID: 19727575
[TBL] [Abstract] [Full Text] [Related]
15. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.
Daigeler A; Brenzel C; Bulut D; Geisler A; Hilgert C; Lehnhardt M; Steinau HU; Flier A; Steinstraesser L; Klein-Hitpass L; Mittelkötter U; Uhl W; Chromik AM
J Exp Clin Cancer Res; 2008 Dec; 27(1):82. PubMed ID: 19077262
[TBL] [Abstract] [Full Text] [Related]
16. Heterogeneous in vitro effects of doxorubicin on gene expression in primary human liposarcoma cultures.
Daigeler A; Klein-Hitpass L; Chromik MA; Müller O; Hauser J; Homann HH; Steinau HU; Lehnhardt M
BMC Cancer; 2008 Oct; 8():313. PubMed ID: 18959781
[TBL] [Abstract] [Full Text] [Related]
17. Lack of heparan sulfate expression in B-cell lines: implications for Kaposi's sarcoma-associated herpesvirus and murine gammaherpesvirus 68 infections.
Jarousse N; Chandran B; Coscoy L
J Virol; 2008 Dec; 82(24):12591-7. PubMed ID: 18842731
[TBL] [Abstract] [Full Text] [Related]
18. PT-100, a small molecule dipeptidyl peptidase inhibitor, has potent antitumor effects and augments antibody-mediated cytotoxicity via a novel immune mechanism.
Adams S; Miller GT; Jesson MI; Watanabe T; Jones B; Wallner BP
Cancer Res; 2004 Aug; 64(15):5471-80. PubMed ID: 15289357
[TBL] [Abstract] [Full Text] [Related]
19. The expression of bone morphogenetic proteins in osteosarcoma and its relevance as a prognostic parameter.
Sulzbacher I; Birner P; Trieb K; Pichlbauer E; Lang S
J Clin Pathol; 2002 May; 55(5):381-5. PubMed ID: 11986346
[TBL] [Abstract] [Full Text] [Related]
20. The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.
Djerbi M; Screpanti V; Catrina AI; Bogen B; Biberfeld P; Grandien A
J Exp Med; 1999 Oct; 190(7):1025-32. PubMed ID: 10510092
[TBL] [Abstract] [Full Text] [Related]
[Next]
